A third glycopeptide (nephritogenoside) isolated from the glomerular basement membrane

Area of Science:

• Nephrology
• Biochemistry
• Immunology

Background:

• The glomerular basement membrane (GBM) is crucial for kidney filtration.
• Glycopeptides within the GBM play roles in kidney structure and function.
• Understanding GBM components is key to diagnosing and treating kidney diseases.

Purpose of the Study:

• To isolate and characterize a novel glycopeptide from the rat GBM.
• To investigate the biological activity and potential nephritogenicity of this glycopeptide.
• To establish a quantitative method for assessing the glycopeptide's activity.

Main Methods:

• Isolation of a novel glycopeptide from rat GBM.
• Injection of the glycopeptide into homologous animals to assess nephritogenic activity.
• Chemical purification using trichloroacetic acid (TCA) treatment.
• Analysis of glycopeptide composition, including non-dialyzable glucose content.
• Characterization of the non-reducing terminus and Concanavalin A binding.

Main Results:

• A new glycopeptide with nephritogenic activity was isolated.
• Nephritogenic activity strongly correlated with non-dialyzable glucose content.
• Trichloroacetic acid (TCA) effectively removed inactive glycopeptides, purifying the active substance.
• The active glycopeptide has an alpha-D-glucopyranoside non-reducing terminus and binds Concanavalin A.

Conclusions:

• The isolated glycopeptide is a natural substance, not an artifact.
• Non-dialyzable glucose content serves as a quantitative measure of nephritogenic activity.
• This discovery offers potential for new diagnostic approaches in glomerulonephritis.